Companies › BHVN
BIOHAVEN LTD F (BHVN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001935979 · EDGAR filings · Updated 2026-07-17
BIOHAVEN LTD F (BHVN) has reported institutional ownership of 94.3%, with 273 institutional managers holding positions valued at $1.20B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-17 — Initial insider ownership filed (Form 3)
- 2026-07-09 — Current report (8-K) filed
- 2026-07-08 — SCHEDULE 13G/A filed
- 2026-05-27 — Current report (8-K) filed
- 2026-05-15 — SCHEDULE 13G/A filed
- 2026-05-05 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, BIOHAVEN LTD F has 273 institutional holders and institutional ownership of 94.3%.
Insider activity
Insiders reported 18 transactions (6 buys, 0 sells) across 8 reporting insiders, with a net reported value of $34.0M.
Data flags from SEC filings
Related companies
ALPHATEC HLDGS INCORPORATED COM NEW (ATEC) · TAYSHA GENE THERAPIES (TSHA) · U S PHYSICAL THERAPY (USPH) · CONMED CORP COM (CNMD) · ORGANON & CO (OGN) · MOONLAKE IMMUNOTHERAPEUTICS (MLTX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.